Find Clinical Trials | Cedars-Sinai

154 results found

Melanoma

IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in Advanced Melanoma

This study focuses on adults with advanced melanoma (a type of skin cancer) that has spread or cannot be surgically removed. The purpose of the study is to determine whether an experimental drug called IMC-F106C, ...

Multiple Myeloma

Iberdomide Maintenance Therapy Following CAR-T in Multiple Myeloma

This study focuses on individuals who have multiple myeloma that has relapsed (meaning it has come back after prior therapy) and/or refractory (resistant to certain therapies). The purpose of the study is to determine whether ...

Non-Hodgkin's Lymphoma

IPH6501 in Relapsed and/or Refractory Non-Hodgkin Lymphoma

The purpose of this study is to determine the safety and tolerability of an experimental drug called IPH6501, as well as evaluate its activity against cancerous cells causing lymphoma. The study focuses on people who ...

Multiple Myeloma

Janssen Scientific Affairs, LLC, 68284528MMY4006, EAP, openl,MM, ciltacabtagene autoleucel OOS,

Primary Objective: The purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is not available via the local health care ...

Unknown Sites

Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers

The purpose of this study is to evaluate how the combination of the drugs nivolumab and relatlimab might work in people with advanced cancer that is “microsatellite instability high” (MSI-H). Microsatellite instability is a marker ...